December 04, 2019 08:00 - December 05, 2019 - 18:00
BioDataWorld is Europe's largest congress focused on Big Data in pharmaceutical development and healthcare. BioDataWorld 2019 will take place on the 4th and 5th December 2019 in Basel, Switzerland.
Participants are IT leaders, bioinformaticians, clinicians, government representatives, pharma companies, VCs and large-scale projects from all over the world. With the vast quantity of data, there come challenges and questions on how to implement infrastructures and deliver data in a usable format. Welcoming in this new generation of healthcare is a multifaceted effort that requires from academics, commercial businesses, clinicians and pharmaceutical companies and, of course, the patients to discuss how to develop this new exciting field of healthcare. Read more about BioDataWorld 2019 >
Our participation in the BioDataWorld 2019 congress will take place by being part of an IMI BigData for Better Outcomes (BD4BO) Collective. This Collective exists of the following public-private partnerships:
The Innovative Medicines Initiative (IMI) will be represented by Colm Carrol.
By means of participating in panel discussions and a dedicated session The IMI BD4BO Collective aims to show the goals and achievements so far and how conference participants can become involved. The IMI BD4BO public-private partnerships are unique and will showcase the success of strong collaborations between academia, industry, and patients in large-scale data projects.
Would you like to set up a personal meeting during the BioDataWorld Conference 2019?
Weblinks and socials:
IMI BD4BO: Big Data for Better Outcomes (BD4BO) is a comprehensive European research programme aimed at accelerating health care system transformation through the use of big data. This programme is funded by the Innovative Medicines Initiative (IMI). BD4BO develops platforms for standardising and analysing diverse data sets, focusing on outcomes that matter to patients and generating meaningful insights that will help improve health care systems across Europe.
Transformational Big Data: There is already a considerable amount of patient and healthcare data available, but it is needs to be standardised with the right technical solutions. When linked together and managed efficiently, this data will lead to a better understanding of human biology. In addition, the potential of being able to use large scale, routine clinical data can lead to better insights into disease progression, treatment outcomes, and ultimately new drug therapies. Now is the time to scale up to address the challenges for healthcare providers, life sciences and pharmaceutical industry in better meeting the needs of patients.
The IMI BD4BO projects are BigData@Heart (Heart Diseases), EHDEN - European Health Data and Evidence Network – disease agnostic), HARMONY (Blood Cancer / Hematologic Malignancies), PIONEER (Prostate Cancer) and ROADMAP (Alzheimer’s Disease). These projects will contribute to healthcare system change through: Definition of outcome metrics, protocols, education, processes and tools to access high-quality data, methodologies and analytics to drive improvements that increase patient engagement
Receive the latest news. Click here to subscribe!